CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • EAR Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Eargo (EAR)

Company Profile
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. The Company's innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. The company believes that Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA registered, exempt Class I or Class 2 devices for the treatment of hearing loss. The Company's differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States. The company’s 4th generation product, the Eargo Neo HiFi, was launched in January 2020 and features improved capabilities across audio fidelity and bandwidth.

Company profile

Ticker
EAR
Exchange
NASDAQ
Website
eargo.com
Employees
Incorporated
Delaware
Location
California
Fiscal year end
Dec 31
Sector
Manufacturing > Electromedical and Electrotherapeutic Apparatus Manufacturing
Industry (SIC)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Avanos Medical • Edwards Lifesciences • Invacare • MSA Safety • Align Technology • Surgalign ...
SEC CIK
0001719395
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Eargo Hearing, Inc. • Eargo Screening, LLC ...
IRS number
273879804

EAR stock data

Latest filings (excl ownership)
View all
8-K
Material Modifications to Rights of Security Holders
17 Jan 23
8-K
Entry into a Material Definitive Agreement
13 Jan 23
8-K
Eargo to Complete a 1-for-20 Reverse Stock Split
11 Jan 23
8-K
Hearing Wellness Pioneer Eargo Launches
4 Jan 23
S-1
IPO registration
16 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Dec 22
8-K/A
Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes into Shares of Eargo Common Stock
12 Dec 22
8-K
Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder
7 Dec 22
8-K
Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes into Shares of Eargo Common Stock
29 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Nov 22
Transcripts
View all
EAR
Earnings call transcript
2022 Q3
6 Nov 22
EAR
Earnings call transcript
2022 Q2
9 Aug 22
EAR
Earnings call transcript
2021 Q2
13 Aug 21
EAR
Earnings call transcript
2021 Q1
13 May 21
EAR
Earnings call transcript
2020 Q4
26 Feb 21
Latest ownership filings
View all
SC 13G/A
BlackRock Inc.
6 Jan 23
SC 13D/A
Nan Fung Group Holdings Ltd
16 Dec 22
SC 13D/A
New Enterprise Associates 15, L.P.
12 Dec 22
4
Donald J Spence
9 Dec 22
4
Onkarr Narula
9 Dec 22
4
Afshin Justin Sabet-Peyman
9 Dec 22
4
Trit Garg
9 Dec 22
3
Afshin Justin Sabet-Peyman
9 Dec 22
3
Trit Garg
9 Dec 22
3
Onkarr Narula
9 Dec 22

Financial summary

Financial statements Chart EAR financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 88.08 mm 88.08 mm 88.08 mm 88.08 mm 88.08 mm 88.08 mm
Cash burn (monthly) 6.19 mm 5.70 mm 16.88 mm 13.27 mm 4.66 mm 11.82 mm
Cash used (since last report) 24.12 mm 22.22 mm 65.82 mm 51.75 mm 18.18 mm 46.10 mm
Cash remaining 63.95 mm 65.85 mm 22.25 mm 36.33 mm 69.90 mm 41.98 mm
Runway (months of cash) 10.3 11.6 1.3 2.7 15.0 3.6

Beta Read what these cash burn values mean

Financial data from Eargo earnings reports.

Institutional ownership, Q3 2022

EAR institutional ownership history Ownership history
60.4% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 50 65 -23.1%
Opened positions 9 15 -40.0%
Closed positions 24 35 -31.4%
Increased positions 13 11 +18.2%
Reduced positions 15 26 -42.3%
13F shares Current Prev Q Change
Total value 447.42 mm 444.78 mm +0.6%
Total shares 23.82 mm 26.55 mm -10.3%
Total puts 764.30 k 59.90 k +1176.0%
Total calls 315.60 k 236.50 k +33.4%
Total put/call ratio 2.4 0.3 +856.2%
Largest owners Shares Value Change
NEA Management 4.52 mm $4.75 mm 0.0%
New Enterprise Associates 15 4.52 mm $150.07 mm 0.0%
Gilde Healthcare Holding B.V. 3.31 mm $180.06 mm 0.0%
Nan Fung 2.89 mm $3.03 mm 0.0%
Alger Associates 1.96 mm $39.15 mm 0.0%
Longitude Capital Partners IV 1.92 mm $64.33 mm 0.0%
Renaissance Technologies 1.05 mm $1.11 mm +81.4%
Oasis Management 711.39 k $747.00 k +191.7%
BLK Blackrock 602.98 k $633.00 k +16.1%
Vanguard 406.50 k $427.00 k -49.4%
Largest transactions Shares Bought/sold Change
Newtyn Management 0.00 -1.31 mm EXIT
Nantahala Capital Management 0.00 -1.03 mm EXIT
Renaissance Technologies 1.05 mm +472.64 k +81.4%
Oasis Management 711.39 k +467.49 k +191.7%
Citadel Advisors 28.88 k -456.61 k -94.1%
Vanguard 406.50 k -397.47 k -49.4%
Susquehanna International 396.12 k +275.20 k +227.6%
BK Bank Of New York Mellon 158.26 k +143.26 k +955.1%
Ergoteles 0.00 -134.60 k EXIT
Millennium Management 170.65 k -130.24 k -43.3%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

EAR insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
7 Dec 22 Spence Donald J Stock Options Common Stock Grant Acquire A No No 0.73 117,194 85.55 k 117,194
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
23 Jan 23
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
23 Jan 23
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.
Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
23 Jan 23
Gainers Jeffs' Brands Ltd (NASDAQ: JFBR) rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
13 Dec 22
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
13 Dec 22

Press releases

From Benzinga Pro
Eargo Effects 1-for-20 Reverse Stock Split
17 Jan 23
SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES
4 Jan 23
EARGO 7 OFFERS CLARITY MODE, CREATING ITS MOST NATURAL HEARING EXPERIENCE FOR THOSE WITH MILD TO MODERATE HEARING LOSS NEW OTC DEVICE TO BE AVAILABLE IN-STORE THROUGH PARTNERSHIP WITH VICTRA, ONE OF AMERICA'S LARGEST
Eargo and NationsBenefits Announce Strategic Partnership
12 Dec 22
SAN JOSE, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, and NationsBenefits, (a leading provider
NationsBenefits and Eargo Announce Partnership to Offer Over-the-Counter Hearing Aids
12 Dec 22
CapitalGainsReport Sector Spotlight: Medical Device Stocks (WHSI, BHC, GMVD, EAR)
12 Dec 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn